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Abstract
Objective: The present study explores bleeding manifestations in routine dental surgical procedures, evaluates 
the influence of antithrombotic drugs upon bleeding risk, and validates the efficiency of a clinical method for the 
measurement of bleeding.
Material and method: A prospective observational study was made involving a cohort of 99 patients in the setting 
of normal clinical practice, with the added conduction of prior hematological tests including baseline hemostasis 
and platelet function, based on a new method (Multiplate System®). For evaluation of the bleeding manifestations, 
a clinical method was selected that evaluates bleeding on the basis of its duration and the hemostatic measures 
needed to resolve the problem.
Results: Almost one-third of the patients (27.3%) were receiving treatment with oral antiplatelet drugs, while 
19.2% received oral anticoagulants and 9% received combined therapy with acetylsalicylic acid plus clopidogrel. 
In turn, an 8% incidence of moderate bleeding episodes was detected correlated to the ASPI platelet function test 
and to advanced patient age.
Conclusion: The incorporation of platelet function tests increases the safety of oral surgery in elderly patients 
subjected to antiplatelet treatment, particularly with acetylsalicylic acid and clopidogrel.
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Introduction
Bleeding is one of the most frequent complications in 
dental practice, and can be produced by the use of inva-
sive techniques or the existence of alterations in hemos-
tasis of a primary (congenital) or secondary (acquired) 
nature associated with certain systemic illnesses and/or 
the administration of certain drugs.
Many dental patients are elderly, with a high prevalence 
of chronic systemic diseases and a frequent need for 
multiple drug treatments. In this context, attention is 
drawn to the administration of antithrombotic drugs, 
which is growing at an annual rate of over 10%. This in 
turn leads to an increase in the detection of secondary 
hemostatic alterations that complicate dental treatment 
and the management of these patients, with an increase 
in the risk of bleeding (1).
The blood is a fluid tissue, and the hemostatic system is 
in charge of preventing its extravasation in the event of 
blood vessel damage. Classically, hemostasis is charac-
terized by two phases: primary and secondary. The pri-
mary phase fundamentally involves the vascular- and 
platelet-mediated processes that ensure the early arrest 
of bleeding as a result of early clot formation. Second-
ary hemostasis in turn generates a fibrin clot to secure 
definitive sealing of the damaged blood vessel and re-
pair. In fact, under normal conditions all these process-
es coexist in a permanent balance between coagulation 
/ anticoagulation and fibrinolysis / antifibrinolysis, and 
bleeding or thrombosis result when this balanced is in-
clined in favor of one process or the other.
A well compiled clinical history should detect any 
bleeding antecedents, allowing the dental surgeon to 
obtain an idea of the type of hemostatic alterations the 
patient may have, and to determine whether such altera-
tions are of a point nature attributable to purely local 
factors, or whether the patient has a constitutional ten-
dency towards bleeding.
Different criteria are used in general surgical proce-
dures to assess the intensity of perioperative bleeding, 
though its estimation is not very rigorous in most stud-
ies, and consensus has not been established on this is-
sue in the scientific community. One of the most widely 
used indicators is the Bleeding Severity Index (BSI), 
which assesses the need for blood product transfusions 
and stratifies the severity of bleeding into three levels 
according to the blood product units transfused: mild 
(transfusion of 1 to < 2 red cell concentrate units), mod-
erate (transfusion of 2 to < 3 units) or severe (transfu-
sion of 3 or more units)(2).
In relation to oral procedures, most of the reviewed 
studies make no mention of the methodology used to 
measure bleeding. Nevertheless, those methods that 
have been described in the literature involve different 
approaches. Vicente Barrero et al. (3) divide postopera-
tive bleeding into three levels: mild when bleeding last 
less than 5 minutes, moderate when it last more than 5 
minutes, and intense when transfusion proves necessary. 
On the other hand, Morimoto et al. (4) make a distinc-
tion between postoperative bleeding that subsides upon 
applying pressure with a piece of gauze, and severe 
bleeding that does not subside with pressure and which 
requires intervention by the oral surgeon to ensure he-
mostasis (compression, removal of the hematoma, cu-
rettage, the application of oxidized cellulose, suturing, 
etc.). Krishnan et al. (5) define prolonged postoperative 
bleeding as bleeding that persists despite the applica-
tion of gauze and pressure in the extraction socket dur-
ing 30 minutes. In turn, clinically significant bleeding 
is taken to be bleeding that persists 12 hours after the 
procedure, gives rise to patient consultation or a visit 
to the emergency room, produces important hematoma 
in the soft tissues, or requires blood transfusion. On 
the other hand, Al-Belasy et al. (6) used a more pre-
cise method in which postoperative bleeding is divided 
into three levels: mild bleeding that subsides in under 
20 minutes upon applying pressure with a piece of ster-
ile gauze; moderate bleeding that does not subside with 
such measures and requires tranexamic acid irrigation 
for two minutes and tamponade with tranexamic acid 
impregnated gauze for 20 minutes; and severe bleeding 
that requires further suturing, the administration of vi-
tamin K, or the infusion of fresh frozen plasma.
The frequency and diagnostic importance of bleeding 
manifestations of the oral cavity that exceed the setting 
of dental practice makes it necessary to use and evalu-
ate objective, precise and effective bleeding measure-
ment methods, with an analysis of the repercussion of 
antithrombotic drugs upon bleeding risk.
The aims of the present study are to explore bleeding 
manifestations in dental surgical procedures, evaluate 
the influence of antithrombotic drugs upon bleeding 
risk, and validate the efficiency of a clinical method for 
the measurement of bleeding after dental extraction or 
oral surgery.
Materials and Methods
A prospective observational study was made involving 
a cohort of 99 patients subjected to successive rand-
omized recruitment without limitations in terms of se-
verity or complexity. The patients were enrolled from 
among the subjects seen in the Stomatology Units of Dr. 
Peset University Hospital (Valencia, Spain) and Castel-
lón General Hospital (Castellón, Spain). Only terminally 
ill patients were excluded, and the study was approved 
by the ethics committees of the two hospital centers.
All patients were attended according to the routine 
clinical practice protocols applied in the respective hos-
pital units. Those patients receiving antiplatelet medica-
tion and programmed for simple tooth extraction were 
subjected to dental surgery without suppression of the 
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antiplatelet medication. In the case of complex proce-
dures (multiple extractions, impacted dental surgery, bi-
opsies) or combined antiplatelet treatment, the patients 
were referred to the Service of Hematology to plan the 
management approach. In the case of patients receiving 
oral anticoagulation and programmed for simple dental 
procedures, the international normalized ratio (INR) 
was monitored, and if the anticoagulation values proved 
compatible with surgery, the dental operation was car-
ried out. In the case of complex procedures, the patients 
were likewise referred to the Service of Hematology for 
programming of the required anticoagulation regimen.
On the first visit, a clinical history was compiled, and 
blood tests were requested, comprising a complete 
blood count, Quick index, INR, activated partial throm-
boplastin time (aPTT), fibrinogen and platelet function 
tests (TRAP test, ASPI test, ADP test, ADPHS test).
The following methodology was used: an ADVIA 120 
automatic analyzer® was used for the complete blood 
count; the coagulation parameters were established with 
an ACL automatic coagulometer® (TOP 3G version 
28.2); and the platelet function tests were performed 
with the Multiplate System analyzer®, with four dif-
ferent and simultaneous tests for each patient sample: 
TRAP test, ASPI test, ADP test and ADPHS test. The 
TRAP test allows the detection of glycoprotein IIb/IIIa 
antagonists (abciximab, tirofiban and eptifibatide) even 
in samples exposed to acetylsalicylic acid (ASA, aspi-
rin) and clopidogrel. The ASPI test is a specific assay 
for the discrimination of acetylsalicylic acid, while the 
ADP test detects the presence of clopidogrel, prasug-
rel and ticlopidine. Finally, the ADPHS test comprises 
the addition of an endogenous inhibitor to the ADP test, 
making it more sensitive in detecting clopidogrel and 
related drugs. This technology is simple, rapid and con-
venient for application as part of the preoperative pa-
tient workup. The system is compact, and its 5 channels 
applying different stimulants allow the performance 
of parallel tests in a sequence lasting 10-15 minutes. 
Processing requires 0.3 ml of whole blood per test, and 
is carried out by an integrated computer system with 
automatic pipetting.
Evaluation of the bleeding manifestations was based 
on an easily quantifiable and objective clinical method 
in which bleeding is assessed according to its duration 
and the hemostatic measures needed to stop bleeding. 
Accordingly, three levels of bleeding intensity were de-
fined: mild (subsides in under 10 minutes with sterile 
gauze tamponade), moderate (subsides with tamponade 
plus local hemostatic treatment in under 60 minutes) 
and severe (bleeding for over 60 minutes and requiring 
other medical or surgical management).
For data collection, a form was developed documenting 
different demographic parameters, patient antecedents, 
acquired and congenital bleeding risk factors, simple 
or complex dental procedures, bleeding manifestations 
(mild, moderate, severe), complications, and a range of 
laboratory test data.
The statistical analysis was carried out using the SPSS® 
version 15.0 statistical package for Microsoft Windows. 
The descriptive study of the continuous variables was 
based on the measures of central tendency and disper-
sion (mean and standard deviation), while the categori-
cal variables were reported as absolute and percentage 
frequencies.
The evaluation of bleeding risk was based on logistic re-
gression analysis involving the continuous and categori-
cal variables. The results of the logistic regression anal-
ysis were presented as the Odds Ratio (OR) and corre-
sponding 95% confidence interval (95%CI). Statistical 
significance was accepted for p < 0.05 in all tests.
Results
The mean age of the patients (n=99) was 57.7 ± 19.9 
years (range 15-93). There was a slight female predomi-
nance (51.5% versus 48.5% males). The biometric profile 
of the study sample revealed the presence of two large 
groups corresponding to the 30-40 years age interval 
and particularly to the 60-80 years age interval.
In relation to the disease antecedents, which moreover 
were those expected of elderly patients, the most com-
mon problems were cardiovascular diseases (40.4%), 
followed by arterial hypertension (38.4%). In turn, 
11.1% of the patients were diabetic, 10% suffered renal 
failure, 2% had neoplastic processes, and 5.1% present-
ed thromboembolic complications (Table 1).
As a result of the mentioned comorbidities, the pa-
tients showed an important use of drug substances. 
The mean number of drugs per patient was 3.24 (range 
0-11). Twenty-seven percent of the patients used oral 
antiplatelet drugs. Specifically, 9% received combined 
therapy with ASA plus clopidogrel, 17.2% used ASA, 
10.1% received clopidogrel, 20% used low molecular 
weight heparin (LMWH), 19.27% were administered 
oral anticoagulants, and 15.2% received nonsteroidal 
antiinflammatory drugs (NSAIDs) other than ASA (Ta-
ble 1). These percentages were significantly higher than 
those reported for the general population, and are ex-
plained by the high prevalence of comorbid conditions 
and the advanced age of the subjects.
 A total of 99 dental procedures were carried out, of 
which 51 were simple procedures and 38 complex pro-
cedures (impacted tooth surgery and multiple extrac-
tions). Most of the bleeding manifestations (92%) were 
classified as mild. There were 8 cases of moderate 
bleeding that subsided with the adoption of local hemo-
static measures in under 60 minutes (Table 2). Of the 8 
patients who suffered moderate bleeding, 5 were receiv-
ing treatment with oral antiplatelet drugs, including four 
with combined ASA and clopidogrel therapy, while one 
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received ASA in monotherapy. In turn, three patients 
were treated with LMWH, two with other NSAIDs, and 
only one with oral anticoagulants. On the other hand, 
one patient presented a history of diabetes mellitus, four 
had arterial hypertension, and 5 suffered cardiovascular 
alterations.
The blood count and coagulation parameters showed no 
significant correlation to bleeding risk. 
In relation to moderate bleeding risk following the den-
tal procedure and patient age, the logistic regression 
analysis showed age to influence risk, with OR 1.05 
(95%CI: 0.99-1.11). Although statistical significance 
was not reached, a clear tendency was noted. In turn, 
the logistic regression analysis showed the variable 
ASPI to be significantly correlated to bleeding, with OR 
0.97 (95%CI: 0.94-0.99, p=0.038).
 Disease antecedents Frequency 
Diabetes mellitus 11.1% 
Arterial hypertension 38.4% 
Renal failure 10.1% 
Neoplasm 2% 
Cardiovascular alterations 40.4% 
Thromboembolic complications 5.1% 
Antithrombotic treatment and 
NSAIDs 
Frequency 
ASA 17.2% 
Clopidogrel 10.1% 
ASA + clopidogrel 9.1% 
Oral anticoagulants 19.2% 
LMWH 20.2% 
NSAIDs 15.2% 
Table 1. Disease antecedents, antithrombotic treatment and NSAIDs.

Bleeding No. patients ASA Clopidogrel LMWH Oral anticoagulants NSAIDs 
Mild 91 12 6 17 18 13 
Moderate 8 5 4 3 1 2 
Severe 0 ------- ------- ------- ------- ------- 
Table 2. Relationship between bleeding and antithrombotic treatment and NSAIDs.
ASA = acetylsalicylic acid
LMWH = low molecular weight heparin
NSAIDs = nonsteroidal antiinflammatory drugs
ASA = acetylsalicylic acid
LMWH = low molecular weight heparin
NSAIDs = nonsteroidal antiinflammatory drugs
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Discussion
A relevant finding in this study has been the detection of 
an 8% incidence of moderate bleeding episodes, signifi-
cantly related to the ASPI platelet function test, and the 
tendency of older patients to show an increased risk of 
moderate bleeding. This is particularly important con-
sidering that one-third of the patients were receiving 
treatment with oral antiplatelet drugs, and that 9% of 
these subjects were using combined treatment with ASA 
and clopidogrel. In coincidence with the general popula-
tion, most of our patients tended to show blood clotting 
in under 10 minutes after tooth extraction – such bleed-
ing being classified as mild. Perhaps as a consequence 
of the patient sample size involved, no cases of severe 
bleeding were recorded – such problems almost always 
being associated with alterations of hemostasis and/or 
local pathological alterations of the treated tissues (he-
mangioma, important local inflammation).
Of the total dental procedures, more than a third (38%) 
were complex (impacted tooth surgery, multiple ex-
tractions). In this setting, of the 8 moderate bleeding 
episodes, three were recorded in patients subjected to 
complex procedures and 5 in simple extractions – no 
significant correlation being established between the 
complexity of the procedure and moderate bleeding 
risk. This incidence of moderate bleeding was related to 
the rigorous method used to detect and register such ep-
isodes. The number of patients with moderate bleeding 
goes not allow us to draw conclusions, though particu-
larly older age and the use of ASA and/or NSAIDs up 
until the time of the dental operation appear to be bleed-
ing risk factors in patients subjected to oral surgery – 
especially among subjects over 65 years old (7). In re-
lation to bleeding and the results obtained in patients 
subjected to antiplatelet treatment, it should be taken 
into account that the evaluation of platelet function was 
made one week before surgery, and that with the excep-
tion of ASA – which was not suspended in the case of 
simple dental procedures – treatment with clopidogrel 
and combined treatment with ASA and clopidogrel was 
always either modified or suppressed. This systematic 
approach was in line with the protocols normally used 
in both study centers.
As regards the analysis of platelet function, a new tech-
nique was used: the Multiplate System® analyzer, based 
on platelet impedance aggregometry. For years, the first 
and only option for evaluating platelet function was 
bleeding time. The impossibility of correct standardi-
zation, and particularly the patient discomfort caused 
(skin and blood vessel damage), gradually lessened the 
use of this technique. Posteriorly, the need to evaluate 
platelet function led to the development of technologies 
such as the PFA-100, a precise, convenient and reliable 
method that assesses platelet function globally and au-
tomatically in citrated whole blood (8,9). However, this 
system does not detect the effect of certain antiplatelet 
drugs upon platelet function (10-12).
A recent introduction on the market has been the men-
tioned Multiplate System® analyzer, which uses dif-
ferent tests to generate reliable information on platelet 
function and on the effects of antiplatelet treatment. 
Recent studies support the usefulness of this new tech-
nology in discriminating among platelet functional al-
terations – particularly those attributable to the use of 
antiplatelet drugs (13-15).
At present, the usual approach in the perioperative 
management of antiplatelet treatment is to carry out 
simple extraction procedures without suppressing the 
antiplatelet medication (16-19). In the case of complex 
procedures or of combined antiplatelet treatment, the 
patient should be referred to the Service of Hematology 
for evaluation of the best approach (20). This sometimes 
implies delays in oral surgery that may not be justified 
in all cases. Likewise, no platelet function tests are nor-
mally carried out in elderly patients, despite the fact that 
the present study suggests that advanced age influences 
at least one of the investigated platelet function tests, 
with an increase in the risk of bleeding.
A significant finding of this study is the fact that 8% of 
the patients subjected to oral surgery suffered moderate 
bleeding. The risk of bleeding was significantly corre-
lated to the ASPI test, and advanced age showed a near-
significant association to moderate bleeding risk. As a 
result, and in contrast to the tendency seen for patient 
age, an increased ASPI test value indicates increased 
patient protection against bleeding (20).
In conclusion, the results of this study suggest that in-
corporation of the new platelet function tests to the pr-
eoperative workup of certain complex dental patients 
seen in the hospital setting may increase the efficiency 
and safety of the surgical procedures.
Likewise, the study has validated the usefulness of the 
proposed new bleeding measurement method in oral 
surgery.
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